Trial · NCT00423670
Participant flow48
How many started, completed or left each group, period by period.
1 to 20 of 48
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period | STARTED | Arm 1. PEG +RBV for 48 Wks (Part I) | 104 | |
| Treatment Period | STARTED | Arm 2. PEG + RBV + BOC for 28 Wks (Part I) | 107 | |
| Treatment Period | STARTED | Arm 3. PEG + RBV + BOC (From Wk 4) for 24 Wks (Part I) | 103 | |
| Treatment Period | STARTED | Arm 4. PEG +RBV + BOC for 48 Wks (Part I) | 103 | |
| Treatment Period | STARTED | Arm 5. PEG + RBV + BOC (From Wk 4) for 44 Wks (Part I) | 103 | |
| Treatment Period | STARTED | Arm 6. PEG + RBV + BOC for 48 Wks (Part II) | 16 | |
| Treatment Period | STARTED | Arm 7. PEG +Low-dose RBV + BOC for 48 Wks (Part II) | 59 | |
| Treatment Period | STARTED | Arm 8. PEG + RBV + BOC (From Wk 24) for 48 Wks (Part I) | 36 | |
| Treatment Period | COMPLETED | Arm 1. PEG +RBV for 48 Wks (Part I) | 52 | |
| Treatment Period | COMPLETED | Arm 2. PEG + RBV + BOC for 28 Wks (Part I) | 77 | |
| Treatment Period | COMPLETED | Arm 3. PEG + RBV + BOC (From Wk 4) for 24 Wks (Part I) | 76 | |
| Treatment Period | COMPLETED | Arm 4. PEG +RBV + BOC for 48 Wks (Part I) | 63 | |
| Treatment Period | COMPLETED | Arm 5. PEG + RBV + BOC (From Wk 4) for 44 Wks (Part I) | 76 | |
| Treatment Period | COMPLETED | Arm 6. PEG + RBV + BOC for 48 Wks (Part II) | 8 | |
| Treatment Period | COMPLETED | Arm 7. PEG +Low-dose RBV + BOC for 48 Wks (Part II) | 28 | |
| Treatment Period | COMPLETED | Arm 8. PEG + RBV + BOC (From Wk 24) for 48 Wks (Part I) | 15 | |
| Treatment Period | NOT COMPLETED | Arm 1. PEG +RBV for 48 Wks (Part I) | 52 | |
| Treatment Period | NOT COMPLETED | Arm 2. PEG + RBV + BOC for 28 Wks (Part I) | 30 | |
| Treatment Period | NOT COMPLETED | Arm 3. PEG + RBV + BOC (From Wk 4) for 24 Wks (Part I) | 27 | |
| Treatment Period | NOT COMPLETED | Arm 4. PEG +RBV + BOC for 48 Wks (Part I) | 40 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00423670/flow